Q2 Holdings, Inc.
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| (unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $472,393 | $358,560 |
| Restricted cash | 2,139 | 2,233 |
| Investments | 96,341 | 88,066 |
| Accounts receivable, net | 69,877 | 42,084 |
| Contract assets, current portion, net | 6,236 | 7,888 |
| Prepaid expenses and other current assets | 20,407 | 23,512 |
| Deferred solution and other costs, current portion | 29,514 | 26,611 |
| Deferred implementation costs, current portion | 10,359 | 9,706 |
| Total current assets | 707,266 | 558,660 |
| Property and equipment, net | 24,572 | 31,528 |
| Right of use assets | 28,687 | 30,402 |
| Deferred solution and other costs, net of current portion | 26,818 | 28,116 |
| Deferred implementation costs, net of current portion | 29,319 | 26,408 |
| Intangible assets, net | 82,317 | 94,633 |
| Goodwill | 512,869 | 512,869 |
| Contract assets, net of current portion and allowance | 12,361 | 9,483 |
| Other long-term assets | 2,492 | 2,696 |
| Total assets | $1,426,701 | $1,294,795 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $8,132 | $9,354 |
| Accrued liabilities | 26,793 | 18,239 |
| Accrued compensation | 23,415 | 32,949 |
| Convertible notes, current portion | 493,933 | 190,331 |
| Deferred revenues, current portion | 170,289 | 137,700 |
| Lease liabilities, current portion | 9,088 | 10,327 |
| Total current liabilities | 731,650 | 398,900 |
| Convertible notes, net of current portion | — | 302,115 |
| Deferred revenues, net of current portion | 28,645 | 27,281 |
| Lease liabilities, net of current portion | 36,063 | 38,346 |
| Other long-term liabilities | 7,458 | 10,357 |
| Total liabilities | 803,816 | 776,999 |
| Commitments and contingencies (Note 8) | ||
| Stockholders' equity: | ||
| Preferred stock: $0.0001 par value; 5,000 shares authorized, no shares issued or outstanding as of September 30, 2025 and December 31, 2024 | — | — |
| Common stock: $0.0001 par value; 150,000 shares authorized, 62,510 issued and outstanding as of September 30, 2025 and 60,728 shares issued and outstanding as of December 31, 2024 | 6 | 6 |
| Additional paid-in capital | 1,257,400 | 1,183,893 |
| Accumulated other comprehensive loss | (1,856) | (1,873) |
| Accumulated deficit | (632,665) | (664,230) |
| Total stockholders' equity | 622,885 | 517,796 |
| Total liabilities and stockholders' equity | $1,426,701 | $1,294,795 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands, except per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Revenues | $201,704 | $175,021 | $586,587 | $513,419 |
| Cost of revenues | 92,859 | 85,962 | 272,188 | 255,281 |
| Gross profit | 108,845 | 89,059 | 314,399 | 258,138 |
| Operating expenses: | ||||
| Sales and marketing | 26,401 | 25,558 | 79,965 | 78,736 |
| Research and development | 38,932 | 36,901 | 113,699 | 107,522 |
| General and administrative | 31,705 | 31,495 | 95,061 | 92,954 |
| Amortization of acquired intangibles | — | 4,776 | 93 | 14,392 |
| Lease and other restructuring charges | 803 | 3,129 | 2,548 | 5,222 |
| Total operating expenses | 97,841 | 101,859 | 291,366 | 298,826 |
| Income (loss) from operations | 11,004 | (12,800) | 23,033 | (40,688) |
| Other income (expense): | ||||
| Interest and other income | 5,487 | 4,617 | 15,076 | 11,658 |
| Interest and other expense | (1,283) | (1,354) | (4,164) | (3,766) |
| Total other income, net | 4,204 | 3,263 | 10,912 | 7,892 |
| Income (loss) before income taxes | 15,208 | (9,537) | 33,945 | (32,796) |
| Provision for income taxes | (160) | (2,260) | (2,380) | (5,904) |
| Net income (loss) | $15,048 | $(11,797) | $31,565 | $(38,700) |
| Other comprehensive income (loss): | ||||
| Unrealized gain (loss) on available-for-sale investments | 65 | 383 | (12) | 560 |
| Foreign currency translation adjustment | (483) | 230 | 29 | (42) |
| Comprehensive income (loss) | $14,630 | $(11,184) | $31,582 | $(38,182) |
| Net income (loss) per common share | ||||
| Basic | $0.24 | $(0.20) | $0.51 | $(0.65) |
| Diluted | $0.23 | $(0.20) | $0.49 | $(0.65) |
| Weighted average common shares outstanding | ||||
| Basic | 62,458 | 60,310 | 62,015 | 59,974 |
| Diluted | 69,858 | 60,310 | 65,076 | 59,974 |
Q2 HOLDINGS INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
(in thousands)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Total stockholders' equity, beginning balances | $584,335 | $480,665 | $517,796 | $448,479 |
| Common stock and additional paid-in capital: | ||||
| Beginning balances | 1,233,486 | 1,134,468 | 1,183,899 | 1,075,284 |
| Stock-based compensation expense | 23,920 | 25,636 | 69,289 | 73,372 |
| Exercise of stock options | — | — | 547 | 8,404 |
| Issuance of common stock under ESPP | — | — | 3,671 | 3,044 |
| Ending balances | 1,257,406 | 1,160,104 | 1,257,406 | 1,160,104 |
| Accumulated deficit: | ||||
| Beginning balances | (647,713) | (652,597) | (664,230) | (625,694) |
| Net income (loss) | 15,048 | (11,797) | 31,565 | (38,700) |
| Ending balances | (632,665) | (664,394) | (632,665) | (664,394) |
| Accumulated other comprehensive loss: | ||||
| Beginning balances | (1,438) | (1,206) | (1,873) | (1,111) |
| Other comprehensive income (loss) | (418) | 613 | 17 | 518 |
| Ending balances | (1,856) | (593) | (1,856) | (593) |
| Total stockholders' equity, ending balances | $622,885 | $495,117 | $622,885 | $495,117 |
| Common stock (in shares): | ||||
| Beginning balances | 62,442 | 60,283 | 60,728 | 59,031 |
| Exercise of stock options | — | — | 12 | 234 |
| Issuance of common stock under ESPP | — | — | 49 | 95 |
| Shares issued for the vesting of restricted stock awards | 68 | 118 | 1,721 | 1,041 |
| Ending balances | 62,510 | 60,401 | 62,510 | 60,401 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $31,565 | $(38,700) |
| Adjustments to reconcile net income (loss) to net cash from operating activities: | ||
| Amortization of deferred implementation, solution and other costs | 21,983 | 19,851 |
| Depreciation and amortization | 40,888 | 52,819 |
| Amortization of debt issuance costs | 1,628 | 1,517 |
| Amortization of premiums and discounts on investments | (934) | (852) |
| Stock-based compensation expense | 66,767 | 69,456 |
| Deferred income taxes | (897) | 2,074 |
| Lease restructuring and impairments | 103 | 1,608 |
| Other non-cash items | 536 | (377) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (27,965) | (14,793) |
| Prepaid expenses and other current assets | 4,485 | (5,937) |
| Deferred solution and other costs | (12,098) | (9,110) |
| Deferred implementation costs | (14,013) | (12,769) |
| Contract assets, net | (1,225) | 4,102 |
| Other long-term assets | 4,340 | 4,557 |
| Accounts payable | (1,409) | (6,311) |
| Accrued liabilities | (2,141) | 1,696 |
| Deferred revenues | 33,944 | 30,520 |
| Deferred rent and other long-term liabilities | (7,792) | (6,635) |
| Net cash provided by operating activities | 137,765 | 92,716 |
| Cash flows from investing activities: | ||
| Purchases of investments | (91,503) | (67,347) |
| Maturities of investments | 84,150 | 75,555 |
| Purchases of property and equipment | (4,812) | (5,253) |
| Capitalized software development costs | (16,175) | (17,589) |
| Net cash used in investing activities | (28,340) | (14,634) |
| Cash flows from financing activities: | ||
| Debt issuance costs related to revolving credit agreement | — | (942) |
| Proceeds from exercise of stock options and ESPP | 4,218 | 11,448 |
| Net cash provided by financing activities | 4,218 | 10,506 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 96 | (72) |
| Net increase in cash, cash equivalents and restricted cash | 113,739 | 88,516 |
| Cash, cash equivalents and restricted cash, beginning of period | 360,793 | 233,632 |
| Cash, cash equivalents and restricted cash, end of period | $474,532 | $322,148 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Property and equipment acquired and included in accounts payable and accrued liabilities | $542 | $930 |
| Stock-based compensation for capitalized software development | $1,515 | $2,270 |
- Organization and Description of Business
Q2 Holdings, Inc. and its wholly-owned subsidiaries, collectively the Company or Q2, is a leading provider of digital solutions to financial institutions, financial technology companies, or FinTechs, and alternative finance companies, or Alt-FIs, wishing to incorporate banking into their customer engagement and servicing strategies. The Company's solutions transform the ways in which its customers engage with account holders and end users, or End Users, enabling them to deliver robust suites of digital banking, digital lending and relationship pricing, and banking-as-a-service, or BaaS, services that make it possible for account holders and End Users to transact and engage anytime, anywhere and on any device. The Company delivers its solutions to the substantial majority of its customers using a software-as-a-service, or SaaS, model under which its customers pay subscription fees for the use of the Company's solutions. The Company was incorporated in Delaware in March 2005 and is a holding company that owns 100% of the outstanding capital stock of Q2 Software, Inc. The Company's headquarters are located in Austin, Texas.
- Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
These interim unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP, and Securities and Exchange Commission, or SEC, requirements for interim financial statements. The interim unaudited condensed consolidated financial statements include the accounts of Q2 Holdings, Inc. and its direct and indirect wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
In the Company's opinion, the interim unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and include all adjustments, consisting of normal, recurring adjustments, necessary for a fair presentation. Certain information and disclosures normally included in the notes to the annual consolidated financial statements prepared in accordance with GAAP have been omitted from these interim unaudited condensed consolidated financial statements pursuant to the rules and regulations of the SEC. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the accompanying notes for the fiscal year ended December 31, 2024, which are included in the Company's Annual Report on Form 10-K ("Form 10-K"), filed with the SEC on February 12, 2025. The results of operations for the three and nine months ended September 30, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2025 or for any other period.
Use of Estimates
The preparation of the interim unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the interim unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses. Significant items subject to such estimates include: revenue recognition; estimate of credit losses; fair value of certain stock awards issued; the carrying value of goodwill; the fair value of acquired intangibles; the useful lives of property and equipment and long-lived intangible assets; the impairment assessment of long-lived assets; and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, restricted cash, investments, accounts receivable and contract assets. The Company's cash and cash equivalents, restricted cash and investments are placed with high credit quality financial institutions and issuers, and at times may exceed federally insured limits. The Company has not experienced any loss relating to cash and cash equivalents or restricted cash in these accounts. The Company provides credit, in the normal course of business, to a majority of its customers. The Company performs periodic credit evaluations of its customers' financial condition and generally does not require collateral. No individual customer accounted for 10% or more of revenues for the three and nine months ended September 30, 2025 and 2024. No customer accounted for 10% or more of accounts receivable, net as of September 30, 2025 and December 31, 2024.
Summary of Significant Accounting Policies
There were no material changes to our significant accounting policies during the nine months ended September 30, 2025 compared to the significant accounting policies described in our Form 10-K.
Basic and Diluted Net Income (Loss) per Common Share
The following table sets forth the computations of net income (loss) per share for the periods listed:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Basic net income (loss) per share | ||||
| Numerator: | ||||
| Net income (loss) | $15,048 | $(11,797) | $31,565 | $(38,700) |
| Denominator: | ||||
| Weighted-average common shares outstanding, basic | 62,458 | 60,310 | 62,015 | 59,974 |
| Net income (loss) per common share, basic | $0.24 | $(0.20) | $0.51 | $(0.65) |
| Diluted net income (loss) per share | ||||
| Numerator: | ||||
| Net income (loss) | $15,048 | $(11,797) | $31,565 | $(38,700) |
| Interest expense, net of tax(1) | 845 | — | — | — |
| Adjusted net income (loss) used in diluted computations | $15,893 | $(11,797) | $31,565 | $(38,700) |
| Denominator: | ||||
| Weighted-average common shares outstanding, basic | 62,458 | 60,310 | 62,015 | 59,974 |
| Effect of potentially dilutive shares: | ||||
| Stock options, restricted stock units, market stock units and performance stock units | 2,600 | — | 3,056 | — |
| Shares issuable pursuant to the ESPP | 7 | — | 5 | — |
| Shares related to convertible notes(2) | 4,793 | — | — | — |
| Weighted-average common shares outstanding, diluted | 69,858 | 60,310 | 65,076 | 59,974 |
| Net income (loss) per common share, diluted | $0.23 | $(0.20) | $0.49 | $(0.65) |
(1)Interest expense has been tax effected using the combined federal and blended state rate of 24.9% for the three and nine months ended September 30, 2025.
(2)The dilutive impact of the convertible senior notes was calculated using the if-converted method. The convertible senior notes were antidilutive for the nine months ended September 30, 2025. Convertible debt becomes anti-dilutive when the combined impact of the interest expense, net of tax, per common share obtainable upon conversion exceeds basic earnings per share.
Due to a net loss, basic and diluted income (loss) per share were the same for the three and nine months ended September 30, 2024, as the effect of all potentially dilutive securities would have been anti-dilutive. The following table sets forth the anti-dilutive common share equivalents for the periods listed:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Stock options, restricted stock units, market stock units and performance stock units | 127 | 5,104 | 104 | 5,104 |
| Shares issuable pursuant to the ESPP | — | 68 | — | 68 |
| Shares related to convertible notes | — | 4,793 | 4,793 | 4,793 |
| Anti-dilutive shares excluded from diluted income per common share | 127 | 9,965 | 4,897 | 9,965 |
Recent Accounting Pronouncements
In September 2025, the Financial Accounting Standards Board, or FASB, issued ASU No. 2025-06, "Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." The amendments are intended to reduce diversity in practice and provide clearer criteria for determining which implementation and development costs should be capitalized versus expensed. The ASU is effective for annual periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Entities may apply a prospective transition approach, a modified transition approach, or a retrospective transition approach. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements and related disclosures.
In July 2025, the FASB issued ASU No. 2025-05, "Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets" which provides targeted improvements to the guidance for measuring expected credit losses. The amendments are intended to enhance consistency in application and clarify the treatment of certain financial assets within the scope of Topic 326. The ASU is effective for annual periods beginning after December 15, 2025, and interim periods within those annual reporting periods, on a prospective basis. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements and related disclosures.
In November 2024, the FASB issued ASU No. 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses" which requires public companies to disclose additional information about certain costs and expenses in the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027, on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its financial statement disclosures.
In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvement to Income Tax Disclosures" which requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The ASU is effective for annual periods beginning after December 15, 2024, on a prospective basis. The Company is currently evaluating the impact that the adoption of this standard will have on its financial statement disclosures.
- Revenues
Revenue Recognition
Revenues are recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services over the term of the agreement, generally when the Company's solutions are implemented and made available to its customers. The promised consideration may include fixed amounts, variable amounts or both. Revenues are recognized net of sales credits and allowances.
Disaggregation of Revenue
Revenue-generating activities are directly related to the sale, implementation and support of the Company's solutions within a single operating segment. The Company derives the majority of its revenues from subscription fees for the use of its solutions hosted in either the Company's third-party data centers or with third-party public cloud service providers, transactional revenue from bill-pay solutions and remote deposit products, revenues for professional services and implementation services related to its solutions and certain third-party related pass-through fees.
The following table disaggregates the Company's revenue by major source:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Subscription | $165,218 | $140,592 | $477,929 | $407,013 |
| Transactional | 17,886 | 16,797 | 53,237 | 50,927 |
| Services and other | 18,600 | 17,632 | 55,421 | 55,479 |
| Total revenues | $201,704 | $175,021 | $586,587 | $513,419 |
Deferred Revenues
The net increase in the deferred revenue balance for the nine months ended September 30, 2025 was primarily driven by the amounts due in advance of satisfying the Company's performance obligations of $623.2 million for current year invoices, partially offset by the recognition of $458.2 million of revenue recognized from current year invoices, the recognition of $128.3 million of revenue that was included in the deferred revenue balance as of December 31, 2024 and $2.7 million from the netting of contract assets and liabilities on a contract-by-contract basis. Amounts recognized from deferred revenues represent primarily revenue from the sale of subscription and implementation services.
Remaining Performance Obligations
On September 30, 2025, the Company had $2.52 billion of remaining performance obligations, which represents contracted revenue minimums that have not yet been recognized, including amounts that will be invoiced and recognized as revenue in future periods. The Company expects to recognize approximately 53% of its remaining performance obligations as revenue in the next 24 months, an additional 34% in the next 25 to 48 months, and the balance thereafter.
Allowance for Credit Losses
The Company is exposed to credit losses primarily through sales of products and services. The Company assesses the collectability of outstanding contract assets on an ongoing basis and maintains a reserve which is included in the allowance for credit losses for contract assets deemed uncollectible. The Company analyzes the contract asset portfolio for significant risks by considering historical collection experience and forecasting of future collectability to determine the amount of revenue that will ultimately be collected from its customers. Customer type (whether a customer is a financial institution or other digital solution provider) has been identified as the primary specific risk affecting the Company's contract assets, and the estimate for losses is analyzed quarterly and adjusted as necessary. Future collectability may be impacted by current and anticipated economic conditions that could impact the Company's customers. Additionally, specific allowance amounts may be established to record the appropriate provision for customers that have a higher probability of default. Nominal amounts were provisioned by the Company for expected credit losses for the nine months ended September 30, 2025 and 2024, andno charges were taken against the allowance at either September 30, 2025 or 2024. The allowance for credit losses related to contract assets was $0.03 million and $0.02 million as of September 30, 2025 and December 31, 2024, respectively.
The Company assesses the collectability of outstanding accounts receivable on an ongoing basis and maintains an allowance for credit losses for accounts receivable deemed uncollectible. The Company analyzes the accounts receivable portfolio for significant risks and considers prior periods and forecasts future collectability to determine the amount of revenues that will ultimately be collected from its customers. This estimate is analyzed quarterly and adjusted as necessary. Identified risks pertaining to the Company's accounts receivable include the delinquency level and customer type. Future collectability may be impacted by current and anticipated economic conditions that could impact the Company's customers. Due to the short-term nature of such receivables, the estimate of the amount of accounts receivable that may not be collected is based on aging of the accounts receivable balances and the financial condition of customers. Historically, the Company's collection experience has not varied significantly, and bad debt expenses have been insignificant. Nominal amounts were provisioned by the Company for the expected losses for the nine months ended September 30, 2025 and 2024, and nominal charges were taken against the allowance at each of September 30, 2025 and 2024. The allowance for credit losses related to accounts receivable was $0.4 million and $0.3 million as of September 30, 2025 and December 31, 2024, respectively.
- Fair Value Measurements
The carrying values of the Company's financial assets not measured at fair value on a recurring basis, principally accounts receivable, restricted cash and accounts payable, approximated their fair values due to the short period of time to maturity or repayment.
Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The current accounting guidance for fair value measurements defines a three-level valuation hierarchy for disclosures as follows:
Level I—Unadjusted quoted prices in active markets for identical assets or liabilities;
Level II—Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; and
Level III—Unobservable inputs that are supported by little or no market activity, which requires the Company to develop its own assumptions.
The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
The following table details the fair value hierarchy of the Company's financial assets measured at fair value on a recurring basis as of September 30, 2025:
| Fair Value Measurements Using: | ||||
|---|---|---|---|---|
| Fair Value | Quoted Prices in Active Markets for Identical Assets(Level I) | Significant Other Observable Inputs(Level II) | Significant Unobservable Inputs (Level III) | |
| Assets | ||||
| Cash Equivalents: | ||||
| Money market funds | $59,267 | $59,267 | $— | $— |
| U.S. government securities | 2,000 | 2,000 | — | — |
| $61,267 | $61,267 | $— | $— | |
| Investments: | Fair Value | Quoted Prices in Active Markets for Identical Assets(Level I) | Significant Other Observable Inputs(Level II) | Significant Unobservable Inputs (Level III) |
| Corporate bonds and commercial paper | $43,386 | $— | $43,386 | $— |
| Certificates of deposit | 10,767 | — | 10,767 | — |
| U.S. government securities | 41,501 | — | 41,501 | — |
| $95,654 | $— | $95,654 | $— | |
The following table details the fair value hierarchy of the Company's financial assets measured at fair value on a recurring basis as of December 31, 2024:
| Fair Value Measurements Using: | ||||
|---|---|---|---|---|
| Fair Value | Quoted Prices in Active Markets for Identical Assets(Level I) | Significant Other Observable Inputs(Level II) | Significant Unobservable Inputs (Level III) | |
| Assets | ||||
| Cash Equivalents: | ||||
| Money market funds | $63,945 | $63,945 | $— | $— |
| Certificates of deposit | 245 | — | 245 | — |
| $64,190 | $63,945 | $245 | $— | |
| Investments: | Fair Value | Quoted Prices in Active Markets for Identical Assets(Level I) | Significant Other Observable Inputs(Level II) | Significant Unobservable Inputs (Level III) |
| Corporate bonds and commercial paper | $46,702 | $— | $46,702 | $— |
| Certificates of deposit | 14,092 | — | 14,092 | — |
| U.S. government securities | 26,922 | — | 26,922 | — |
| $87,716 | $— | $87,716 | $— | |
The Company determines the fair value of the vast majority of its debt investment holdings based on pricing from its pricing vendors. The valuation techniques used to measure the fair value of financial instruments having Level II inputs were derived from non-binding consensus prices that are corroborated by observable market data or quoted market prices for similar instruments. Such market prices may be quoted prices in active markets for identical assets (Level I inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level II inputs).
- Cash, Cash Equivalents and Investments
The Company's cash, cash equivalents and investments as of September 30, 2025 and December 31, 2024 consisted primarily of cash, U.S. government securities, corporate bonds, commercial paper, certificates of deposit, money market funds and other equity investments. The Company considers all highly liquid investments acquired with an original maturity of ninety days or less at the date of purchase to be cash equivalents. Cash equivalents are stated at cost or fair value based on the underlying security. Restricted cash consists of deposits held as collateral for the Company's secured letters of credit or bank guarantees issued in place of security deposits for the Company's corporate headquarters and various other leases and deposits held by the Company on behalf of its medical insurance carrier reserved for the use of claim payments.
The Company classifies its debt investments as available-for-sale at the time of purchase and reevaluates such classification as of each balance sheets date. All debt investments are recorded at estimated fair value. Unrealized gains and losses on available-for-sale investments are included in accumulated other comprehensive income (loss), a component of stockholders' equity. If the Company does not expect to recover the entire amortized cost basis of the available-for-sale debt security, it considers the available-for-sale debt security to be impaired. For individual debt securities classified as available-for-sale and deemed impaired, the Company assesses whether such decline has resulted from a credit loss or other factors. Impairment relating to credit losses is recorded through a reserve, limited to the amount that the fair value is less than the amortized cost basis. Impairment is reported in other income (expense), net on the condensed consolidated statements of comprehensive income (loss). Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net on the condensed consolidated statements of comprehensive income (loss). Interest, amortization of premiums and accretion of discount on all debt investments classified as available-for-sale are also included as a component of other income (expense), net on the condensed consolidated statements of comprehensive income (loss). Based on the Company's assessment, no impairments for credit losses were recognized during either of the nine months ended September 30, 2025 or 2024.
The Company has invested in a private financial technology investment fund, classified as an equity investment. Equity investments without a readily determinable fair value, where the Company has no influence over the operating and financial policies of the investee, are recorded at cost, less impairment and adjusted for subsequent observable price changes obtained from orderly transactions for identical or similar investments issued by the same investee. An impairment charge to current earnings is recorded when the cost of the investment exceeds its fair value and this condition is determined to be other-than-temporary. During the nine months ended September 30, 2025, the Company determined there wasno other-than-temporary impairment on its equity investment. This equity investment had a carrying amount of $0.7 million and $0.3 million as of September 30, 2025 and December 31, 2024, respectively.
As of September 30, 2025 and December 31, 2024, the Company's cash was $411.1 million and $294.4 million, respectively.
A summary of the Company's cash equivalents and investments that are carried at fair value as of September 30, 2025 is as follows:
| Cash Equivalents: | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
|---|---|---|---|---|
| Money market funds | $59,267 | $— | $— | $59,267 |
| U.S. government securities | 2,000 | — | — | 2,000 |
| $61,267 | $— | $— | $61,267 | |
| Investments: | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
| Corporate bonds and commercial paper | $43,336 | $55 | $(5) | $43,386 |
| Certificates of deposit | 10,760 | 7 | — | 10,767 |
| U.S. government securities | 41,473 | 30 | (2) | 41,501 |
| $95,569 | $92 | $(7) | $95,654 |
A summary of the Company's cash equivalents and investments that are carried at fair value as of December 31, 2024 is as follows:
| Cash Equivalents: | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
|---|---|---|---|---|
| Money market funds | $63,945 | $— | $— | $63,945 |
| Certificates of deposit | 245 | — | — | 245 |
| $64,190 | $— | $— | $64,190 | |
| Investments: | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
| Corporate bonds and commercial paper | $46,626 | $104 | $(28) | $46,702 |
| Certificates of deposit | 14,076 | 20 | (4) | 14,092 |
| U.S. government securities | 26,917 | 22 | (17) | 26,922 |
| $87,619 | $146 | $(49) | $87,716 |
Investments may be sold or may settle at any time, without significant penalty, for use in current operations or for other purposes, even if they have not yet reached maturity. As a result, the Company classifies its investments, including investments with maturities beyond twelve months, as current assets on the condensed consolidated balance sheets.
The following table summarizes the estimated fair value of the Company's debt investments, designated as available-for-sale and classified by the contractual maturity date of the investments as of the dates shown:
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Due within one year or less | $87,578 | $49,460 |
| Due after one year through two years | 8,076 | 38,256 |
| $95,654 | $87,716 |
The Company has certain available-for-sale debt investments in a gross unrealized loss position. The Company regularly reviews its debt investments for impairment resulting from credit loss using both qualitative and quantitative criteria, as necessary, based on the composition of the portfolio at period end. The Company considers factors such as the length of time and extent to which the market value has been less than the cost, the financial position and near-term prospects of the issuer or whether the Company has the intent to or it is more likely than not it will be required to sell the investments before recovery of the investments' amortized-cost basis. If the Company determines that impairment exists in one of these investments, the respective investments would be written down to fair value. For debt securities, the portion of the write-down related to credit loss would be recognized in other income, net on the condensed consolidated statements of comprehensive income (loss) if the intent of the Company was to sell the investments before recovery. Any portion not related to credit loss would be included in accumulated other comprehensive loss in the condensed consolidated balance sheets. Because the Company does not intend to sell any investments which have an unrealized loss position at this time, and it is not more likely than not that the Company will be required to sell the investment before recovery of its amortized cost basis, which may be maturity, the reserve for available-for-sale debt securities waszero as of September 30, 2025 and December 31, 2024.
The following table presents the fair values and the gross unrealized losses of these available-for-sale debt investments as of September 30, 2025, aggregated by investment category and the length of time that individual securities have been in a continuous loss position:
| Less than 12 months | 12 months or greater | |||
|---|---|---|---|---|
| Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | |
| Corporate bonds and commercial paper | $4,290 | $(4) | $1,953 | $(1) |
| Certificates of deposit | 748 | — | — | — |
| U.S. government securities | 1,228 | (2) | — | — |
| $6,266 | $(6) | $1,953 | $(1) | |
The following table presents the fair values and the gross unrealized losses of these available-for-sale debt investments as of December 31, 2024, aggregated by investment category and the length of time that individual securities have been in a continuous loss position:
| Less than 12 months | 12 months or greater | |||
|---|---|---|---|---|
| Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | |
| Corporate bonds and commercial paper | $19,229 | $(28) | $— | $— |
| Certificates of deposit | 1,722 | (4) | 248 | — |
| U.S. government securities | 9,882 | (17) | — | — |
| $30,833 | $(49) | $248 | $— | |
- Goodwill and Intangible Assets
The carrying amount of goodwill was $512.9 million at both September 30, 2025 and December 31, 2024. Goodwill represents the excess purchase price over the fair value of net assets acquired. The annual impairment test was performed as of October 31, 2024. No impairment of goodwill was identified during 2024, nor has any impairment of goodwill been identified during the nine months ended September 30, 2025.
Intangible assets at September 30, 2025 and December 31, 2024 were as follows:
| As of September 30, 2025 | As of December 31, 2024 | |||||
|---|---|---|---|---|---|---|
| Gross Amount | Accumulated Amortization | Net Carrying Amount | Gross Amount | Accumulated Amortization | Net Carrying Amount | |
| Customer relationships | $— | $— | $— | $1,495 | $(1,401) | $94 |
| Acquired technology | 150,097 | (129,303) | 20,794 | 150,097 | (112,791) | 37,306 |
| Capitalized software development costs | 98,380 | (36,857) | 61,523 | 81,080 | (23,847) | 57,233 |
| $248,477 | $(166,160) | $82,317 | $232,672 | $(138,039) | $94,633 | |
The Company recorded intangible assets from various prior business combinations as well as capitalized software development costs. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which range from four toseven years. During the three months ended September 30, 2025 and 2024, the Company capitalized software development costs of $6.1 million and $6.5 million, respectively, and $17.7 million and $19.9 million for the nine months ended September 30, 2025 and 2024, respectively. Amortization expense included in cost of revenues on the condensed consolidated statements of comprehensive income (loss) was $10.1 million and $9.0 million for the three months ended September 30, 2025 and 2024, respectively, and $29.5 million and $25.9 million for the nine months ended September 30, 2025 and 2024, respectively. Amortization expense included in operating expenses on the condensed consolidated statements of comprehensive income (loss) waszero and $4.8 million for the three months ended September 30, 2025 and 2024, respectively, and $0.1 million and $14.4 million for the nine months ended September 30, 2025 and 2024, respectively.
During the period ended September 30, 2025, the Company recognized an impairment loss related to capitalized software development costs for certain software assets that are no longer expected to be recoverable. The Company calculated the impairment by comparing the carrying amount of the asset to its estimated fair value using a discounted cash flow model. As a result, the Company recorded an impairment charge of $0.4 million to research and development expense within the Company's condensed consolidated statements of comprehensive income (loss) during the three and nine months ended September 30, 2025.
The estimated future amortization expense related to intangible assets as of September 30, 2025 was as follows:
| Amortization | |
|---|---|
| Year Ended December 31, | |
| 2025 (October 1 to December 31) | $9,444 |
| 2026 | 34,197 |
| 2027 | 18,264 |
| 2028 | 12,037 |
| 2029 | 6,580 |
| Thereafter | 1,795 |
| Total amortization | $82,317 |
- Leases
The Company leases office space under non-cancellable operating leases for its corporate headquarters in Austin, Texas, intwo adjacent buildings under separate lease agreements. Pursuant to the first agreement, the Company leases office space with an initial term that expires on April 30, 2028, with the option to extend the lease for an additionalten-year term. The Company is not reasonably certain to exercise the renewal under this agreement, therefore no amount related to this option is recognized as part of lease liabilities or right of use assets. Pursuant to the second agreement, the Company leases office space with lease terms of approximatelyten years, with an option to extend the lease on the second building from five toten years. The Company also leases office space in other U.S. cities located in Nebraska, Iowa and North Carolina. Internationally, the Company leases offices in India and Australia, and from time to time, employees may work from flexible office spaces in the U.S. and internationally.
During the nine months ended September 30, 2025, the Company recorded $4.0 million in lease liabilities related to the renewals and expansions of our office lease agreements. The Company recognized corresponding right of use assets of $3.3 million, net of $0.7 million in tenant lease improvement allowances. As of September 30, 2025, the Company has receivedno reimbursements for this allowance, and has a remaining allowance receivable of $0.7 million included as a component of prepaid expenses and other current assets on the Company's condensed consolidated balance sheets. The Company believes its current facilities are adequate to meet its current needs and that suitable additional or alternative space will be available on commercially reasonable terms as needed to support future growth.
Maturities of the Company's operating lease liabilities for lease terms in excess of one year at September 30, 2025 were as follows:
| Operating Leases | |
|---|---|
| Year Ended December 31, | |
| 2025 (October 1 to December 31) | $3,001 |
| 2026 | 10,795 |
| 2027 | 9,684 |
| 2028 | 6,468 |
| 2029 | 4,947 |
| Thereafter | 18,522 |
| Total lease payments | 53,417 |
| Less: imputed interest | (8,266) |
| Total operating lease liabilities | $45,151 |
The operating lease liabilities include $11.3 million in optional lease renewals where the Company is reasonably certain of exercising those options.
The Company has exited and made available for sublease certain leased office spaces, and updated assessments of previously exited leased office spaces. As a result, the Company evaluated the recoverability of its right of use and other lease related assets and determined that their carrying values were not fully recoverable. The Company calculated the impairment by comparing the carrying amount of the asset group to its estimated fair value using a discounted cash flow model. During the three and nine months ended September 30, 2025, impairment charges of $0.5 million were recorded to right of use assets. These charges were recorded within operating expenses on the condensed consolidated statements of comprehensive loss.
- Commitments and Contingencies
The Company has non-cancelable contractual commitments related to the 2026 Notes and the 2025 Notes (each as defined below) as well as the related interest. The interest on the 2026 Notes is payable semi-annually on June 1 and December 1 of each year. The interest on the 2025 Notes is payable semi-annually on May 15 and November 15 of each year. See Note 9 - Debt for additional information about the Company's convertible senior notes. The Company also has non-cancelable contractual commitments for certain third-party products, stadium sponsorship costs, commitment fees associated with the Company's Revolving Credit Agreement, third-party public cloud service provider fees and other product costs. Several of these purchase commitments for third-party products contain both a contractual minimum obligation and a variable obligation based upon usage or other factors which can change on a monthly basis. The estimated amounts for usage and other factors are not included within the table below.
Future minimum contractual commitments that have initial non-cancelable terms in excess of one year at September 30, 2025 were as follows:
| Contractual Commitments | |
|---|---|
| Year Ended December 31, | |
| 2025 (October 1 to December 31) | $204,744 |
| 2026 | 370,671 |
| 2027 | 35,061 |
| 2028 | 15,066 |
| 2029 | 182 |
| Thereafter | — |
| Total commitments | $625,724 |
Legal Proceedings
From time to time, the Company is involved in legal proceedings arising both in and outside the ordinary course of its business. The Company is not presently a party to any legal proceedings that it believes, if determined adversely to the Company, would have a material adverse effect on the Company.
In March 2025, the Company agreed to settle a dispute with a former commercial real estate broker related to commissions for the lease of its current headquarters, pursuant to which the Company paid $1.8 million to settle the matter in full. The Company has recorded the entire amount within general and administrative expenses on its condensed consolidated statements of comprehensive income (loss). The Company considers this specific settlement as a non-recurring charge due to the unique nature of the dispute and the underlying facts, which are outside the normal course of its business.
Loss Contingencies
In the ordinary course of business, the Company is subject to loss contingencies that cover a range of matters. An estimated loss from a loss contingency, such as a legal proceeding or claim, is accrued if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated.
- Debt
Convertible Senior Notes
The following table presents details of the Company's convertible senior notes outstanding as of September 30, 2025, which are further discussed below (principal in thousands):
| Date Issued | Maturity Date (1) | Principal | Interest Rate per Annum | Conversion Rate for Each $1,000 Principal (2) | Initial Conversion Price per Share | |
|---|---|---|---|---|---|---|
| 2026 Notes | June 1, 2019 | June 1, 2026 | $303,995 | 0.75% | $11.2851 | $88.61 |
| 2025 Notes | November 15, 2020 | November 15, 2025 | $191,000 | 0.125% | $7.1355 | $140.14 |
(1)Unless earlier converted or repurchased in accordance with their terms prior to such date
(2)Subject to adjustment upon the occurrence of certain specified events
As further defined and described below, the 2026 Notes and the 2025 Notes are collectively referred to as the Notes.
In June 2019, the Company issued $316.3 million principal amount of convertible senior notes due in June 2026, or the 2026 Notes. Interest is payable semi-annually on June 1 and December 1 of each year, commencing on December 1, 2019.
In November 2020, the Company issued $350.0 million principal amount of convertible senior notes due in November 2025, or the 2025 Notes. Interest is payable semi-annually on May 15 and November 15 of each year, commencing on May 15, 2021.
In March 2023, the Company repurchased $12.3 million in aggregate principal amount of the 2026 Notes for $10.7 million in cash and repurchased $159.0 million in aggregate principal amount of the 2025 Notes for $138.4 million in cash. The partial repurchase of the 2026 Notes and 2025 Notes resulted in a $19.9 million gain on early debt extinguishment, of which $1.8 million consisted of unamortized debt issuance costs. This gain was recorded within other income, net on the condensed consolidated statements of comprehensive income (loss). The Company may repurchase additional 2025 Notes and/or 2026 Notes from time to time through open market purchases, block trades, and/or privately negotiated transactions, in compliance with applicable securities laws and other legal requirements. The timing, volume, and nature of the repurchases will be determined by the Company based on the capital needs of the business, market conditions, applicable legal requirements, and other factors.
The Notes are the Company's senior unsecured obligations and rank senior in right of payment to any of the Company's indebtedness that is expressly subordinated in right of payment to the Notes, rank equally in right of payment with any of the Company's indebtedness that is not so subordinated, are effectively junior in right of payment to any of the Company's secured indebtedness to the extent of the value of the assets securing such indebtedness and are structurally junior to all indebtedness and other liabilities (including trade payables) of the Company's current and future subsidiaries.
On or after June 5, 2023 or November 20, 2023 for the 2026 Notes and 2025 Notes, respectively, the Company may redeem for cash all or any portion of the Notes, at the Company's option, if the last reported sale price of the Company's common stock has been at least 130% of the conversion price in effect for at least 20 trading days (whether or not consecutive) during any 30-consecutive trading-day period. If the Company calls any or all of the Notes for redemption, holders may convert all or any portion of their Notes at any time prior to the close of business on the scheduled trading day prior to the redemption date, even if the Notes are not otherwise convertible at such time. After that time, the right to convert such Notes will expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the Notes may convert all or any portion of its Notes until the redemption price has been paid or duly provided for.
On or after March 1, 2026 or August 15, 2025 for the 2026 Notes and 2025 Notes, respectively, holders may convert all or any portion of their Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the succeeding conditions described herein. Upon conversion, the Company will pay or deliver cash, shares of its common stock or a combination of cash and shares of its common stock, at its election, as described in the indentures governing the Notes.
Holders may convert their Notes at their option at any time prior to the close of business on the business day immediately preceding March 1, 2026 or August 15, 2025 for the 2026 Notes and 2025 Notes, respectively, only under the following circumstances:
during any calendar quarter commencing after the calendar quarter ending on September 30, 2019 or March 30, 2021 (and only during such calendar quarter), for the 2026 Notes and 2025 Notes, respectively, if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
during thefive consecutive business day period after anyfive consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day; or
upon the occurrence of specified corporate events.
If a fundamental change (as defined in the relevant indenture governing each of the Notes) occurs prior to the maturity date, holders of each of the Notes may require the Company to repurchase all or a portion of their notes for cash at a repurchase price equal to 100% of the principal amount of the Notes, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
The Notes consist of the following:
| As of September 30, 2025 | As of December 31, 2024 | |||
|---|---|---|---|---|
| 2026 Notes | 2025 Notes | 2026 Notes | 2025 Notes | |
| Principal | $303,995 | $191,000 | $303,995 | $191,000 |
| Unamortized debt issuance costs | (940) | (122) | (1,880) | (669) |
| Net carrying amount | $303,055 | $190,878 | $302,115 | $190,331 |
As of September 30, 2025, the 2026 Notes were not convertible. On August 15, 2025, the 2025 Notes became convertible in accordance with the terms described above. None of the 2025 Notes have been converted since original issuance through the date of this filing. As of September 30, 2025, the if-converted value of the 2026 Notes and 2025 Notes didnot exceed the principal amount. The if-converted values were determined based on the closing price of the Company's stock on September 30, 2025.
Capped Call Transactions
In connection with the issuance of the Notes, the Company entered intotwo separate capped call transactions, or the Capped Calls, with one or more counterparties. The Capped Calls associated with the 2026 Notes have an initial strike price of $88.6124 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2026 Notes. The Capped Calls associated with the 2025 Notes have an initial strike price of $140.1443 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2025 Notes. The Capped Calls associated with the 2026 Notes have an initial cap price of $139.00 per share. The Capped Calls associated with the 2025 Notes have an initial cap price of $211.54 per share. The Capped Calls are expected to offset the potential dilution to the common stock upon any conversion of the Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of the Notes in the event the market price per share of common stock is greater than the strike price of the Capped Call, with such offset subject to a cap. If, however, the market price per share of the common stock exceeds the cap price of the Capped Calls, there would be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that the then-market price per share of the common stock exceeds the cap price. As the Capped Calls are considered indexed to the Company's stock and are considered equity classified, they are recorded in stockholders' equity on the condensed consolidated balance sheets and are not accounted for as derivatives. The cost of $40.8 million incurred in connection with the Capped Calls associated with the 2026 Notes was recorded as a reduction to additional paid-in capital. The cost of $39.8 million incurred in connection with the Capped Calls associated with the 2025 Notes was recorded as a reduction to additional paid-in capital.
In March 2023, in connection with the partial repurchase of the Notes, the Company terminated the Capped Calls in a notional amount corresponding to the aggregate principal amount of the Notes that were repurchased. As a result of the termination of the related Capped Calls, the Company received cash payments of $0.1 million. The proceeds were recorded as an increase to additional paid-in capital on the condensed consolidated balance sheets.
Revolving Credit Agreement
On July 29, 2024, the Company entered into afive-year secured Revolving Credit Agreement with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC and Texas Capital Bank. The Revolving Credit Agreement provides for a revolving line of credit of up to $125.0 million, which may be drawn upon as revolving loans, swingline loans or letter of credit issuances, with sublimits (i) in the case of swingline loans, in an amount up to $20.0 million and (ii) in the case of letters of credit, in an amount up to $10.0 million. Borrowings under the Revolving Credit Agreement may, at the Company's election, bear interest quarterly at either (a) the base rate plus the applicable margin ("Base Rate Loans"), or (b) the adjusted term secured overnight financing rate (the "SOFR"), plus the applicable margin (the "Adjusted Term SOFR Loans"). The applicable margin ranges from 0.75% to 1.50% per annum for Base Rate Loans and 1.75% to 2.50% per annum for Adjusted Term SOFR loans. A commitment fee accrues at a rate ranging from 0.15% to 0.30% per annum, based on the Company's consolidated total net leverage ratio, of the average daily unused portion of the commitment of the lenders.
The Revolving Credit Agreement contains customary representations, warranties, affirmative and negative covenants, including covenants which restrict the ability of the Company, or any of its subsidiaries to, among other things, create liens, incur additional indebtedness and engage in certain other transactions, in each case subject to certain exclusions. In addition, the Revolving Credit Agreement contains certain financial covenants which become effective in the event the Company's liquidity (as defined in the Revolving Credit Agreement) falls below specified levels. The Revolving Credit Agreement contains customary events of default relating to, among other things, payment defaults, breach of covenants, cross-default acceleration to material indebtedness, bankruptcy-related defaults, judgment defaults, and the occurrence of certain change of control events. The occurrence of an event of default may result in the termination of the Revolving Credit Agreement and acceleration of repayment obligations with respect to any outstanding principal amounts. As of September 30, 2025, the Company was in compliance with all financial covenants in the Revolving Credit Agreement.
As of September 30, 2025, $0.7 million of unamortized debt issuance cost related to the Revolving Credit Agreement is included in prepaid expense and other current assets and other long-term assets in the condensed consolidated balance sheets. As of September 30, 2025, the Company hadno outstanding borrowings under the Revolving Credit Agreement.
Interest Expense on Debt
The following table sets forth expenses related to the Notes and Revolving Credit Agreement:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Contractual interest expense | $710 | $696 | $2,136 | $1,955 |
| Amortization of debt issuance costs | 542 | 526 | 1,628 | 1,517 |
| Total | $1,252 | $1,222 | $3,764 | $3,472 |
Debt issuance costs are amortized on a straight-line basis over the expected life of the Notes and the Revolving Credit Agreement, respectively. For the Notes, the straight-line basis approximates the effective interest method. As of September 30, 2025, the remaining period over which the debt issuance costs will be amortized for the 2026 Notes and 2025 Notes was 0.7 years and 0.1 years, respectively.
- Stock-Based Compensation
In March 2014, the Company's board of directors approved the 2014 Equity Incentive Plan, or 2014 Plan. The 2014 Plan terminated on June 1, 2023, except with respect to the outstanding awards previously granted thereunder. As of June 1, 2023, there were 7,606 shares of common stock that were reserved for issuance pursuant to outstanding awards, assuming maximum performance for any performance-based awards, under the 2014 Plan.
In May 2023, the Company's stockholders approved the 2023 Equity Incentive Plan, or 2023 Plan, with an effective date of June 1, 2023, under which stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and units and other cash-based or stock-based awards may be granted to employees, consultants and directors. At time of approval, up to 14,045 shares of common stock were reserved for issuance under the 2023 Plan, all of which consisted of shares previously reserved for issuance under the 2014 Plan and any shares that would otherwise be returned to the 2014 Plan as a result of the forfeiture, repurchase or termination of awards issued under that plan. The 2023 Plan is a successor to and continuation of the Company’s 2014 Plan. As of September 30, 2025,5,371 shares remain authorized and available for future issuance under the 2023 Plan, assuming attainment of maximum performance for any market stock units or performance stock units.
In March 2014, the Company adopted its Employee Stock Purchase Plan, or ESPP. The plan was implemented starting January 3, 2022, pursuant to which certain participating domestic employees are able to purchase shares of the Company's common stock at a 15% discount of the lower of the market price at the beginning or end of the applicable offering period. Offering periods commence on each June 1 and December 1. The Board provided for a share reserve with respect to the ESPP of 800 shares. The ESPP contains a provision that automatically increases the shares available for issuance under the plan on January 1 of each year through 2024, by an amount equal to the lesser of (a)500 shares, (b)1% of the number of shares issued and outstanding on the immediately preceding December 31, or (c) such other amount as may be determined by the Company's board of directors. As of September 30, 2025,1,175 shares remain authorized and available for future issuance under the ESPP.
Stock-based compensation expense was recorded in the following cost and expense categories on the Company's condensed consolidated statements of comprehensive income (loss):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Cost of revenues | $2,323 | $3,010 | $7,603 | $9,575 |
| Sales and marketing | 3,945 | 4,443 | 11,386 | 12,783 |
| Research and development | 4,349 | 4,735 | 12,552 | 13,203 |
| General and administrative | 12,640 | 12,136 | 35,226 | 33,895 |
| Total stock-based compensation expense | $23,257 | $24,324 | $66,767 | $69,456 |
- Income Taxes
In accordance with applicable accounting guidance, the income tax expense for the nine months ended September 30, 2025 is based on the estimated annual effective tax rate for fiscal year 2025. The Company's provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items, valuation allowances, and any applicable income tax credits.
The Company's provision for income taxes reflected an effective tax rate of approximately 1.1% and (23.7)% for the three months ended September 30, 2025 and 2024, respectively and 7.0% and (18.0)% for the nine months ended September 30, 2025 and 2024, respectively. For the three and nine months ended September 30, 2025 and 2024, the Company's effective tax rate was lower than the U.S. federal statutory rate primarily due to its valuation allowance offsetting the benefits of losses. The Company's income tax expenses and benefits consist of federal, state and foreign current and deferred income tax expense from global operations.
On July 4, 2025, the U.S. government enacted tax legislation commonly referred to as the One Big Beautiful Bill Act (the "OBBBA"). Beginning with the 2025 tax year, the OBBBA permanently restores immediate expensing of domestic research and development expenditures and reinstates 100% bonus depreciation, among other provisions. As further guidance is issued by the IRS, the Company may have additional adjustments upon the filing of the relevant tax returns. For the nine months ended September 30, 2025, the OBBBA did not have a material impact on the Company's effective tax rate.
To date, the Company has provided a valuation allowance against most of its deferred tax assets as it believes the objective and verifiable evidence of its historical pretax net losses outweighs any positive evidence of its forecasted future results. The Company will continue to monitor the positive and negative evidence, and it will adjust the valuation allowance as sufficient objective positive evidence becomes available.
As of September 30, 2025, the Company had $1.1 million in uncertain tax positions, including an insignificant amount of accrued interest, representingno change from the balance at December 31, 2024. The Company's tax years 2021 through 2024 generally remain open to examination by the major taxing jurisdictions to which the Company is subject. Operating losses generated in years prior to 2021 remain open to adjustment until the statute of limitations closes for the tax year in which the net operating losses are utilized.
- Segments and Geographic Information
All revenue-generating activities are directly related to the sale, implementation and support of the Company's solutions in a single operating segment. The Company is a leading provider of digital solutions to financial institutions, FinTechs and Alt-FIs, seeking to incorporate banking into their customer engagement and servicing strategies. The Company derives the majority of its revenues from subscription fees for the use of its solutions hosted in either the Company's third-party data centers or with third-party public cloud service providers, transactional revenue from bill-pay solutions and remote deposit products, revenues for professional services and implementation services related to its solutions and certain third-party related pass-through fees. Additionally, see Note 3 - Revenue for additional information about disaggregated revenue.
The Company's chief operating decision maker, or CODM, is the Chief Executive Officer, and the financial information reviewed by the CODM is presented on a consolidated basis for the single operating segment for purposes of allocating resources, evaluating financial performance and monitoring budget versus actual results based on net income (loss) that is also reported on the condensed consolidated statements of comprehensive income (loss). The significant expenses within net income (loss) on which the CODM relies include those that are reported on the condensed consolidated statements of comprehensive income (loss). The measure of the Company's single operating segment assets is reported on the condensed consolidated balance sheets as total assets. Substantially all of the Company's principal operations, assets and decision-making functions are located in the United States.
- Subsequent Events
Share Repurchase Program
In October 2025, the Company's Board of Directors authorized a share repurchase program that authorizes the Company to repurchase up to $150.0 million, or the Repurchase Program, of its common stock. The Repurchase Program permits shares of common stock to be repurchased from time to time at management's discretion, through open market purchases or privately negotiated transactions, including accelerated share repurchase transactions, block trades or pursuant to Rule 10b5-1 trading plans. The timing and number of shares of common stock repurchased will depend on a variety of factors, including but not limited to the market price of our common stock, general business and market conditions, alternative investment opportunities and funding considerations. The Repurchase Program does not obligate the Company to repurchase any specific number or dollar amount of shares and has no expiration date. The Repurchase Program may be modified, suspended or terminated by the Company's Board of Directors at any time. As of November 5, 2025, the Company had not repurchased any shares under the Share Repurchase Program.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.